cancer diagnosis

Robust multiple myeloma treatment program holds promiseThe Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.
Promising treatment developments in lymphoma immunotherapiesIn this Q&A, a physician and lymphoma expert discusses treatment advances and promising signs for the future.
Four ways the genomic data commons will advance cancer careA new cancer database, the Genomic Data Commons, aims to make research more accessible
Clinical stage at diagnosis could affect melanoma survivalNYU researchers suggest a difference in the tumor progression of stage IV melanoma patients based on the initial clinical stage at original diagnosis.
Researchers discuss ‘less is more’ cancer treatment approachMost patients hear the word “carcinoma” or “cancer” and believe they may die if they do not seek treatment. But ASCO researchers say that may be a problematic mentality.
Achieving balance: Providing high-value cancer care
Achieving balance: Providing high-value cancer careHow plans can achieve the right balance between cost and outcomes
Living past cancer: Late effects and long-term care
Living past cancer: Late effects and long-term careWhereas the incidence of cancer among kids is increasing, death from childhood cancer is decreasing.
Managing oncology patients: Communication is key to improving quality of careIt’s no secret that the U.S. cancer care delivery system is in crisis. But when primary care physicians are closely involved during a patient’s cancer treatment, quality of care can improve.
How to talk to patients about prostate cancer screening
How to talk to patients about prostate cancer screeningIn this article, I outline my patient discussion concerning prostate cancer screening, which includes defining what the PSA test is, why to screen or not to screen, the screening controversy, current guidelines, and decision aids.